The MAPK/ERK signaling pathway is one more important target for inhibitors. This pathway is included in controling cell distinction, growth, and survival. Inhibitors targeting MAPK/ERK are employed in cancer therapies to stop uncontrolled cell proliferation and lump development. JAK/STAT signaling inhibitors modulate immune actions and are made use